COO Cannulight Technology Auckland, Auckland, New Zealand
Disclosure(s):
James Stone: Cannulight Technology Limited: CEO and shareholder of Cannulight Technology (Ongoing)
Mike Munley: Cannulight Technology Limited: Consultant (Ongoing)
Dr James Stone will present an economic model which calculates the true costs of each PIVC insertion, and the potential cost savings and patient benefits of introducing a new technology. The model is based on data collected from over 400,000 ED patients in NHS hospitals.
Learning Objectives:
Identify the hidden costs of multiple PIVC attempts.
Assess which key variables are known and which require quantification for their institute(s) to fully utilize the model.
Model top line 'what if' scenarios by using hypothetical data to improve PIVC rates.
